You have requested access to member-only content.
Note from the instructor: Policy Statement issued on billing Medicare beneficiaries for self-administered drugs (SAD)
In a surprising announcement on Friday, October 30, the Office of Inspector General (OIG) may have delivered some good news to hospitals who are diligently following prior CMS guidance on billing patients for SADs provided in the outpatient setting.
This is an excerpt from member-only content. Please log in or become a member.
Log in to access this content:
Unable to log in?
Click here to reset your password or unlock your account.
Forgot your username?
Contact customer care at customerservice@hcpro.com or call 800-650-6787, between 8 AM - 5 PM CT
Not a member? Join now!
Revenue Cycle Advisor is the key to your organization's Medicare regulatory news and education. It combines all of HCPro's Medicare regulatory and reimbursement resources into one handy and easy-to-access portal. News is not just repeated from other sources. It is analyzed by our Medicare experts so professionals can comprehend any new rule updates thoroughly.
For questions and support, please call customer service: 800-650-6787.
Try before you buy with our FREE samples!